Compare Advance Auto Parts, Inc. (AAP) vs AbCellera Biologics Inc (ABCL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Advance Auto Parts, Inc. vs AbCellera Biologics Inc — how do they compare? Advance Auto Parts, Inc. trades at $53.1 (market cap $3.19B), while AbCellera Biologics Inc trades at $9.22 (market cap $2.99B). The key difference: Advance Auto Parts, Inc. and AbCellera Biologics Inc are close in size by market cap, and Advance Auto Parts, Inc. pays a 1.89% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| AAP | ABCL | |
|---|---|---|
Market Cap | $3.19B | $2.99B |
Sector | Consumer Cyclical | Health |
52-Week High | $64.17 | $9.76 |
52-Week Low | $38.75 | $2.78 |
Enterprise Value | $5.47B | $2.58B |
Dividend Yield | 1.89% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Advance Auto Parts, Inc.
Advance Auto Parts is one of the industry's largest retailers of aftermarket automotive parts, tools, and accessories to do-it-yourself customers in North America. Advance operated 4,972 stores as of the end of 2021, in addition to servicing 1,317 independently owned Carquest stores. The company's Worldpac unit is a premier distributor of imported original-equipment parts. Advance derived 58% of its 2021 sales from commercial clients, up from 30%-40% before the General Parts deal.
Read more on AAP →About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →
